Best Hormone therapy doctors: TOP 38 doctors

Content meets the Bookimed Editorial Policy and is medically reviewed by

Fahad Mawlood

Yesim Yildirim

  • 4.6 Excellent 493 reviews
  • 21 years of experience
  • accreditations:
  • Turkey, Istanbul, Anadolu Medical Center
  • Doctor Yesim Yildirim is an oncologist certified by the European Society of Medical Oncology (ESMO). Affiliated with numerous hospitals in the United States and Turkey, including the University of Maryland Medical Center, Johns Hopkins Hospital and Memorial Sisli Hospital. She has over 20 years of experience and has a special interest in preventive medicine, diabetes, and hypertension. Holds an MBA in Healthcare Management and shares her expertise with Bookimed from 2022.

    The Medical Advisory Board expert is a verified credible medical professional with solid theoretical background and practical experience in the field. The expert provides support related to medical content accuracy for medical writers and performs educational workshops to Bookimed coordinators serving patient requests.

    The medical content creation under the expert’s control follows rigorous and well-established procedure to be informative, trustworthy, and transparent and making Bookimed.com a credible source of evidence-based health information.

  • Read more
Doctor's visit
Price on request
Info

Mustafa Solak

  • 4.5 Good 162 reviews
  • 19 years of experience
  • Turkey, Istanbul, Hisar Hospital Intercontinental
  • Dr. Mustafa Solak is a medical oncologist with expertise in breast, testicular, ovarian, lung, head-neck, and gastrointestinal cancers. He graduated from Hacettepe University School of Medicine. He completed his residency at Istanbul Sisli Etfal Teaching and Research Hospital. He then pursued a fellowship at Hacettepe University Cancer Institute.

    Dr. Solak has managed many complex cancer cases. He has contributed to clinical advancements at respected centers, including the University of Texas MD Anderson Cancer Center. He has also worked at Hitit University Corum Training Hospital and Medical Park Hospital. His experience shows a strong commitment to cancer care and research.

  • Read more
Doctor's visit
Price on request
Info

Pelles Sharon

  • 4.4 Good 146 reviews
  • 22 years of experience
  • Israel, Tel Aviv, Sourasky Medical Center (Ichilov)
  • Dr. Pelles Sharon is an oncologist known for her skill in advanced cancer treatments and clinical research. She has led important studies on how cancer patients view and understand clinical trials. Her work has helped improve patient involvement and outcomes.

    Dr. Sharon performs surgeries for colon and stomach cancer, HIPEC, SIRT therapy, and Whipple surgery. She also offers modern treatments such as immunotherapy, targeted therapy, and chemoembolization. She is respected for her high success rates and dedication to evidence-based care.

  • Read more
Doctor's visit
Price on request
Info

David Sarid

  • 4.4 Good 146 reviews
  • 37 years of experience
  • accreditations:
  • Israel, Tel Aviv, Sourasky Medical Center (Ichilov)
  • Dr. David Sarid is a specialist in oncology and radiotherapy based in Israel with expertise in chemotherapy, radiotherapy, and biological cancer therapy. He has been educated in the UK, Israel, and Georgia and has written over 30 articles devoted to cancer treatment. He is a lecturer at Tel Aviv University and a member of several medical organizations.

  • Read more
Doctor's visit
Price on request
Info

Ofer Merimsky

  • 4.4 Good 146 reviews
  • 40 years of experience
  • accreditations:
  • Israel, Tel Aviv, Sourasky Medical Center (Ichilov)
  • Dr. Ofer Merimsly is the best sarcoma, lymphoma, and lung cancer doctor within Israel and in the world. Also specializes in Whipple surgery treatment for patients with pancreatic cancer. Head of the National Center for sarcomas of bone and soft tissues of the Tel Aviv Medical Center Sourasky (Ichilov).

    Specialty:

    • Treatment of all types of lung cancer and thoracic organs
    • Treatment of all types of sarcomas of bone and soft tissue
    • Treatment stromal tumors of the gastrointestinal tract

    Education and specialization:

    • Higher medical education, graduated the Medical Faculty of the Hebrew University of Jerusalem, Israel
    • Residency in General Oncology and Radiotherapy
    • Training in the field of radiotherapy and brachytherapy at New York Hospital, USA
    • Special refresher course for the treatment of tumors of the skeleton and soft tissues, Paris. France

    Membership:

    • President of the Society of oncologists and radiotherapists Israel
    • The American Scientific Cancer Society
    • European scientific medical organization
    • European Society of Oncology of the musculoskeletal system
    • International Society for the treatment of tumors of the connective tissue
  • Read more
Doctor's visit
Price on request
Info

Murat Sari

  • 5 Excellent 3 reviews
  • 9 years of experience
  • Turkey, Istanbul, Medipol Acibadem District Hospital
  • Education and Career


    2011 – 2015, (Internal Medicine Specialist) Istanbul University Istanbul School of Education and Career

    Medicine Department of Internal Medicine

    2015 – 2016, (Internal Medicine) Specialist Istanbul Haydarpasa Numune Training and Research Hospital

    2016 – 2019, (Medical Oncology) Istanbul University Istanbul School of Medicine Department of Medical Oncology

    2019 – 2021, (Medical Oncology Specialist) - Istanbul Haydarpasa Numune Training and Research Hospital

    2021 – 2024, (Associate Professor) Marmara University School of Medicine Department of Medical Oncology

    Memberships in Scientific Organizations

    ASCO

    ESMO

    TTOD 

    AVOD 

    Publications

    In the field of oncology, he has published over 30 peer-reviewed articles at both international and national levels.

    Awards Received

    EAACI The European Academy of Allergy and Clinical Immunology 2019 Best Poster Award

    "The top 3rd verbal presentation, IGICC (11th International Gastrointestinal Cancers Conference – IGICC2021)"

    Speeches Delivered at National Congresses, Conferences, and Symposia:

     

    Courses, Meetings, and Certificates

    ESMO certified Medical Oncologist since 2019

  • Read more
Doctor's visit
Price on request
Info

Find out about the best doctors here

20 top ranked Hormone therapy doctors in the world are represented on this page. The list includes only verified specialists known for their experience and high success rates.

The ranking is composed according to the Bookimed patient reviews and considers the rating of hospitals where doctors practice.

Top 5 Hormone therapy doctors on Bookimed.com:

How to choose the best Hormone therapy doctors in the world?

The specialist’s CV contains details about the doctor’s expertise and work experience, education, scientific research, and languages spoken. Compare information on several specialists, read carefully about their experience, success rates, and methods they apply. Make sure the chosen doctor has relevant experience in the treatment of a medical issue you are looking for. Read reviews of patients who had a consultation with the chosen specialist.

Famous Hormone therapy doctors have vast experience, continue education constantly, participate in professional associations and have positive feedback from patients treated.

What is the cost of a doctor's consultation?

The price for the consultation on Hormone therapy varies between experts and depends on certain factors, such as:

  • the country of practicing
  • the clinical experience and reputation
  • the medical degree and educational background
  • the doctor’s workload
  • medical developments, proprietary techniques used, and awards, if any.

How to make an appointment with a chosen doctor?

To schedule your visit, just submit a request on Bookimed.com. Our coordinator will contact you to discuss the time and details of the appointment, so everything will go smoothly.

We can help to find the right doctors for Hormone therapy if you have any difficulties with a choice. Bookimed services are free for patients ♥

Where you go for medical treatment

Abdullah Sakin

  • 5 Excellent 2 reviews
  • 18 years of experience
  • Turkey, Istanbul, Medipol Bahçelievler Hospital
  •  

    Experience

    2022 PRIVATE MEDIPOL BAHÇELİEVLER HOSPITAL

     

    2021 - 2021 Prof. Dr. Cemil Taşçıoğlu City Hospital, Medical Oncology Clinic Education Officer

     

    2021 - 2021 Prof. Dr. Cemil Taşçıoğlu City Hospital

     

    2020 - 2021 Yüzüncü Yıl University Faculty of Medicine

     

    2020 - 2021 Head of the Department of Medical Oncology, Yüzüncü Yıl University Faculty of Medicine, Assoc. Dr.  

     

    2018 - 2021 Lecturer - Yüzüncü Yıl University Faculty of Medicine, Head of Medical Oncology Department  

     

    2018 - 2021 Yüzüncü Yıl University Faculty of Medicine

     

    2015 - 2018 University of Health Sciences, Okmeydanı Training and Research Hospital

     

    2015 - 2018 University of Health Sciences, Okmeydanı Training and Research Hospital, Medical Oncology Clinic, Sub-branch assistant

     

    2012 - 2015 Kanuni Sultan Süleyman Training and Research Hospital, Internal Medicine specialist

     

    2012 - 2015 Suleiman the Magnificent Training and Research Hospital,

     

    2008 - 2012 Haseki Training and Research Hospital

     

    2006 - 2008 Kızıltepe No. 3 Health Center General Practitioner.

     

     

    Education

    2018

    İstanbul Okmeydanı Eğitim ve Araştırma Hastanesi, Tıbbı Onkoloji

    2018

    İstanbul Okmeydanı Eğitim ve Araştırma Hastanesi, Tıbbı Onkoloji, İstanbul Okmeydanı Eğitim ve Araştırma Hastanesi, Tıbbı Onkoloji

    2012

    İstanbul Haseki Eğitim ve Araştırma Hastanesi, İç Hastalıkları, İstanbul Haseki Eğitim ve Araştırma Hastanesi, İç Hastalıkları

    2012

    İstanbul Haseki Eğitim ve Araştırma Hastanesi, İç Hastalıkları

    2007

    Uludağ Üniversitesi Tıip Fakültesi, Tıip Fakültesi, Uludağ Üniversitesi Tıip Fakültesi, Tıip Fakültesi

     

  • Read more
Doctor's visit
Price on request
Info

Constantinos Zamboglou

  • New
  • 12 years of experience
  • Cyprus, Republic of Cyprus, German Medical Institute (GMI)
  • Education

    09 / 2004 – 07 / 2006                Movie Director School, ANT1 Movie School Athens, Greece, Degree “Television Director”, grade point average: B

    09 / 2006 – 08 / 2008                Medical School, Semmelweis University Budapest, Hungary, Medical preliminary examination (Physikum), grade point average: A

    10 / 2008 – 05 / 2013                Medical School, Albert-Ludwigs-Universität Freiburg, Germany, State examination in medicine, grade point average: A

    02/ 2009 – 02/2012                   Institute of Pharamcology and Toxicology I, Albert-Ludwigs-Universität Freiburg, GermanyDoctoral thesis, grade: summa cum laude

    05 / 2018                                      Basic and advanced course in German drug law and GCP, Clinical Trials Unit, Medical Center - University of Freiburg

    01 / 2019                                      Board certification: Radiotherapy and Radiation Oncology

    03 / 2020                                      Medical Center University of Freiburg, Department of Radiation Oncology, Germany, Habilitation (Postdoctoral lecture qualification)

    09 / 21 – 08 / 23                         MHBA, Friedrich Alexander University, Nuernberg, Germany

    07 / 2022                                      Completion of ISO 9001:2015 training, Nicosia, Cyprus

    Professional Career

    09 / 2013 – 01 / 2019               Medical Center University of Freiburg, Department of Radiation Oncology, Germany, Residency                                                

    07 / 2017 – 07 / 2020               Bertha-Ottenstein programme, Medical Center, University of Freiburg, Germany, Clinician Scientist

    Since 06 / 2019                          Medical Center University of Freiburg, Department of Radiation Oncology, Germany, Consultant

    01 / 2021 – 12 / 2022                Bertha-Ottenstein programme, Medical Center, University of Freiburg, Germany, Advanced Clinician Scientist

    01 / 2021 – 12 / 2021                 Head of the section “Interventional Radiation Oncology”, Medical Center University of Freiburg, Department of Radiation Oncology, Germany

    Since 01 / 2022                         Medical Center University of Freiburg, Department of Radiation Oncology, Germany, Prostate cancer research group leader

    Since 01 / 2022                          German Medical Institute, Limassol, Cyprus, Vice Medical Director

    Professional Memberships and Distinctions

    2010           Sanofi-Aventis poster prize, Annual meeting of the German Society of Pharmacology and Toxicology 2010, Mainz, Germany      

    2017           Poster prize, Annual meeting of the German Society of Radiation Oncology (DEGRO) 2017, Berlin, Germany

    2019           Poster prize, Uro-Oncological Symposium 2019, Magdeburg, Germany

    2020           Invited member of the German expert panel for prostate cancer of the German Society of Radiation Oncology (DEGRO)

    2020           Herman-Holthusen Award, German Society of Radiation Oncology (DEGRO)

    2021           Invited member of the ESTRO-ACROP guideline committee for prostate cancer

    2021           Best Abstract, EMUC congress 2021, Athens, Greece

    2023           Annual ARO study price for the HypoFocal-SBRT study from the German Cancer Foundation

    2023           Invited member of the ESTRO focus group “Urology”

  • Read more
Doctor's visit
Price on request
Info

Ari Raphael

  • 4.4 Good 146 reviews
  • 25 years of experience
  • Israel, Tel Aviv, Sourasky Medical Center (Ichilov)
  • Known Expertise 

    Medical Oncologist 

    Academic Position 

    Senior Lecturer 

    Education

    Bar-Ilan University, Israel / Computational Biology 

    Israeli Society for Health-Tech / Fellowship by IMA/ Innovation and Entrepreneurship in Medicine and Health-Tech 

    Sheba Medical Center and Bar-Ilan University, Israel/ Genomics and Biomedical Informatics 

    Semmelweis University/Doctor of Medicine 

    Training and Specialization 

    Clinical observership in acute oncology, early phase clinical trials and lung cancer/ Guy's and St. Thomas hospital, London, England 

    Leader Shift, Executive Development Program, Tel-Aviv Sourasky Medical Center 

    Fellowship Program in Innovation and Entrepreneurship in Medicine and Health-Tech 

    Resident, Medical Oncology, TASMC, Israel 

    6th year medical school rotations, Kaplan Medical Center, Israel 

    Rotation, intensive care unit and pulmonology, Stony Brook hospital, NY, US 

    Clinical Experience 

    Leader of the TASMC oncology project of PSIFAS, the Israeli National Genomic Medicine Initiative 

    PI for study initiator trial: T-Cell Repertoire sequencing as clinical efficacy tool for pembrolizumab (with platinum based chemotherapy) in advanced NSCLC. 

    PI for study initiator trial: T-cell repertoire sequencing as a clinically efficacy tool for neoadjuvant immunotherapy plus platinum-doublet chemotherapy for resectable NSCLC. 

    Representative of the National Medical Association for the National Council for the Prevention, Diagnosis and Treatment of Malignant Diseases, as well as head of the oncology field, Leumit HMO 

    Consultant on drugs and operations in the field of oncology, Leumit HMO 

    Member of the Helsinki Committee for Clinical Studies, TASMC 

    Primary investigator (PI) in pharmaceutical phases I&III clinical trials Head of oncology day-care service, TASMC, Israel 

    Molecular Tumor Board (MTB) moderator of the Israeli Lung Cancer Society 

    NGS interpretation clinic alongside head of pathology, TASMC, Israel 

    PI for study initiator trial: Genomic Variant of BCL-2 as a Novel Predictor of Response to Paclitaxel, TASMC, Israel 

    Medical oncology clinic in the field of lung and breast cancer, TASMC, Israel

    Leading sub-investigator (SI) in many phase I-III clinical trials in oncology, including intra-tumoral injections (mRNA, viruses and NO), TASMC, Israel 

    Courses 

    Good Clinical Practice ICH GCP R2 & Israeli MOH Guidelines Updated Course 

    Point-of-Care Ultrasound course, Israeli Medical Association 

    GCP training Bioforum 

    GCP training Bioforum

    Investigator Site Personnel ICH GCP Training Certificate - TransCelerate BioPharma 

    Academic Experience 

    Lecturer in the Department of Medical Education at the Faculty of Medical and Health Sciences at Tel Aviv University 

    JIMS Journal Club - Instructor for students. 

    Guidance of Dr. Aviv Berkovich M.D in basic science: cfDNA NGS for identification ofprimary and acquired resistance in patients with Lung Cancer and EGFR mutations. 

    TASMC, Israel in collaboration with The Tisch Cancer Institute Icahn School of Medicine at Mount Sinai, NY USA 

    Training team for oncology residents, TASMC, Israel 

    Mentor for new intern, TASMC, Israel 

    Tutor for medical students in oncology clerkships, Tel-Aviv University, Israel 

    Honors 

    Outstanding teacher in the faculty of medicine, Tel-Aviv University, Israel

     Outstanding teacher in the faculty of medicine, Tel-Aviv University, Israel 

    Sign of honor for reserve medical personnel for the battle in Lebanon, IDF

    Completion of residency final examination (shlav Beit) with honors 

    Israeli society for clinical oncology and radiation therapy (ISCORT) 17 research grant competition winner 

    Affiliations 

    Israeli Medical Association (IMA) 

    Israeli Society for Clinical Oncology and Radiation Therapy (ISCORT) 

    The Israeli Lung Cancer Group (ILCG) 

    European Society of Medical Oncology (ESMO) 

    International Association for the Study of Lung Cancer (IASLC) 

    The International Society of Liquid Biopsy (ISLB) 

    The Israeli Society for Health-Tech 

    Boards 

    Co-founder, board member and treasurer of the Israeli Acute Oncology Society 

    Clinical Research Association Board of Directors on behalf of the Israeli Lung Cancer Group 

    Member of the Trustees of Oncology Innovation, TASMC, Israel 

    Doctor of Medical Service IDF 

    Areas of interest 

    Thoracic malignancies, 

    early to late phase clinical trials, 

    intra-tumoral injections, 

    comprehensive genomic profiling of tumors, 

    liquid biopsies: cfDNA, TCR rep-seq and epi-Genetics; 

    cell therapy

  • Read more
Doctor's visit
Price on request
Info

Irina Stepfansky

  • 4.4 Good 146 reviews
  • 25 years of experience
  • Israel, Tel Aviv, Sourasky Medical Center (Ichilov)
  • Dr. Irina Stepfansky is an oncologist and internal medicine specialist at Sourasky Medical Center. She has more than 25 years of clinical experience. Since 2015, she has directed the Oncology Hospitalization department. Dr. Stepfansky earned her medical degree from Grodno University in Belarus. She completed advanced oncology training at Tel Aviv Medical Center.

    Dr. Stepfansky has been licensed in Israel since 2000. She has led and participated in many phase I-III oncology clinical trials. Her work has helped improve cancer care and patient outcomes. She is recognized for her expertise in both internal medicine and oncology. Dr. Stepfansky has a strong record in research and clinical leadership.

  • Read more
Doctor's visit
Price on request
Info

Phd Viola Fox

  • 4.6 Excellent 58 reviews
  • 13 years of experience
  • Germany, Solingen, Medical Center in Solingen
  • Dr. Viola Fox is the Chief Physician at the Clinic for Haematology, Oncology, and Palliative Medicine at BKZ Solingen. This clinic is a certified interdisciplinary cancer center. Dr. Fox is a leading expert in drug therapy for tumor diseases in Germany and Europe. She has more than 15 years of experience in this field.

    She is a member of the German Society of Oncology and Haemato-oncology (GDHO), the German Association of Physicians, and the American Association for Cancer Research. Dr. Fox is also active in molecular biology research. Her work supports progress in cancer treatment and molecular diagnostics.

    Her main areas of expertise are chemotherapy, immunotherapy, targeted therapy, and radiation therapy. Dr. Fox is known for her innovative methods and strong commitment to patient care. Her efforts have led to high recovery rates and recognition from her peers.

  • Read more
Doctor's visit
Price on request
Info

Sezer Saglam

  • 5 Excellent 34 reviews
  • 28 years of experience
  • accreditations:
  • Turkey, Istanbul, Istanbul Florence Nightingale Hospital
  • Prof. Dr. Sezer Sağlam is a medical oncologist at Gayrettepe Florence Nightingale Hospital. He specializes in gastrointestinal and breast cancers. He has contributed to cancer care through research, especially with his study on the best timing for surgery after neoadjuvant therapy in rectal cancer. This work has influenced global treatment protocols.

    Dr. Sağlam has led clinical trials in targeted therapies and precision medicine. His research on liver-transplanted patients with hepatocellular carcinoma was nominated for the 2024 International Best Researcher Award. He is a member of ASCO, ESMO, and ENET. Dr. Sağlam provides personalized and evidence-based oncology care.

  • Read more
Doctor's visit
Price on request
Info

Nail Paksoy

  • 5 Excellent 2 reviews
  • 14 years of experience
  • accreditation:
  • Turkey, Istanbul, Medipol Bahçelievler Hospital

  • PROFESSIONAL EXPERIENCE

    2011-2012
    Erzurum Koprukoyu State Hospital
    Department: General Medicine

    2012-2017
    Istanbul University Cerrahpaşa Medical Faculty
    Department: Internal Medicine

    06/2017-10/2017
    Istanbul Gaziosmanpasa Taksim Training and Research Hospital
    Department: Internal Medicine

    10/2017-11/2018
    Istanbul University Istanbul Medical Faculty
    Department: Allergy and Immunology Fellowship

    2018/2022
    Istanbul University Oncology Institute
    Department: Medical Oncology Fellowship

    2022-2023
    Tekirdag City Hospital
    Department: Medical Oncology Specialist

    2023-present
    Istanbul Medipol University Medipol Bahcelievler Private Hospital
    Department: Medical Oncology Assoc. Prof.

     

    EDUCATION

    2005-2011
    Medical Education
    Sivas Cumhuriyet University Medical Faculty, Sivas, Turkey

    2012-2017
    Internal Medicine
    Istanbul University Cerrahpaşa Medical Faculty, Department of Internal Medicine, Istanbul, Turkey

    2017-2018
    Allergy-Immunology Fellowship
    Istanbul University Istanbul Medical Faculty
    Department of Internal Medicine, Division of Allergy and Immunology, Istanbul, Turkey

    2018-2022
    Medical Oncology Fellowship
    Istanbul University Oncology Institute, Department of Medical Oncology, Istanbul, Turkey

    2022
    ESMO Board Certification in Medical Oncology
    10th September 2022 in Paris, France.

    2023
    Medical Oncology Assoc. Prof.
    Istanbul Medipol University Department of Medical Oncology, Istanbul, Turkey

     

    INTERNATIONAL CLINICAL TRIALS:

    1. Astefania - ROCHE

    • Title: A Study Evaluating the Efficacy and Safety of Adjuvant Atezolizumab or Placebo and Trastuzumab Emtansine for Participants With HER2-Positive Breast Cancer at High Risk of Recurrence Following Preoperative Therapy
    • Role: Subinvestigator

    2. PFİZER

    • Title: A Study Of Lorlatinib Versus Crizotinib In First-Line Treatment Of Patients With ALK-Positive NSCLC
    • Role: Subinvestigator

    3. RECITE - AMGEN

    • Title: Study of Romiplostim for Chemotherapy-induced Thrombocytopenia in Adult Subjects With Gastrointestinal, Pancreatic, or Colorectal Cancer
    • Role: Subinvestigator

    4. NAVIGATE - BAYER

    • Title: A Study to Test the Effect of the Drug Larotrectinib in Adults and Children With NTRK-fusion Positive Solid Tumors
    • Role: Subinvestigator

    5. RUBY - Tesaro (PRA)

    • Title: A Phase 3, Randomized, Double-blind, Multicenter Study of Dostarlimab (TSR-042) Plus Carboplatin-paclitaxel Versus Placebo Plus Carboplatin-paclitaxel in Patients With Recurrent or Primary Advanced Endometrial Cancer
    • Role: Subinvestigator

    6. ENGOT-ov43/GOG-3036 - MSD

    • Title: Study of Chemotherapy With Pembrolizumab (MK-3475) Followed by Maintenance With Olaparib (MK-7339) for the First-Line Treatment of Women With BRCA Non-mutated Advanced Epithelial Ovarian Cancer (EOC) (MK-7339-001/KEYLYNK001/ENGOT-ov43/GOG-3036)
    • Role: Subinvestigator

    7. ASTRA ZENECA

    • Title: To Study Clinical Effectiveness and Safety of Olaparib Monotherapy in Metastatic Breast Cancer Patients.
    • Role: Subinvestigator

    8. ROSY-O - ASTRA ZENECA

    • Title: Roll Over StudY for Patients Who Have Completed a Previous Oncology Study With Olaparib
    • Role: Subinvestigator
    •  

    INTERNATIONAL PUBLICATIONS

    I. Published journal articles indexed by SCI, SSCI, and AHCI

    Weekly Paclitaxel in Classic Kaposi Sarcoma

    • Authors: Paksoy, N., Khanmammadov, N., Doğan, İ., Ferhatoğlu, F., Ahmed, M. A., Karaman, S., & Aydiner, A.
    • Journal: Medicine, 102(5)

    Carboplatin Desensitization in Ovarian Carcinoma

    • Authors: Paksoy, N., Khanmammadov, N., Doğan, İ., Ferhatoğlu, F., Yildiz, A., Ak, N., & Aydiner, A.
    • Journal: Medicine, 101(45), e31726

    High-Dose Chemotherapy for Ewing’s Sarcoma

    • Authors: Paksoy, N., Ferhatoglu, F., Dogan, İ., Khanmammadov, N., Celik, A. I., Gulbas, Z., & Başaran, M.
    • Journal: Medicine, 101(49), e32213

    Multidrug Refractory TFE3(+) Renal Cell Carcinoma

    • Authors: Paksoy, Nail, et al.
    • Journal: Journal of Oncology Pharmacy Practice, 2022, 28.1: 215-221

    Crizotinib Efficacy in NSCLC with MET Alterations

    • Authors: Gürbüz, M., Kiliçkap, S., Bilici, A., Karadurmuş, N., Sezer, A., Şendur, M. A. N., ... & Demirkazik, A.
    • Journal: Medicine, 101(50), e32368

    Clinicopathological Features in ALK Mutant NSCLC

    • Authors: Dogan, I., Gurbuz, M., Paksoy, N., Ferhatoglu, F., Vatansever, S., Saip, P., ... & Aydiner, A.
    • Journal: Medicine, 101(34)

    PSMA-Based Tumor Burden in Prostate Cancer

    • Authors: HAS SIMSEK, Duygu, et al.
    • Journal: Annals of Nuclear Medicine, 2021, 35.6: 680-690

    Atezolizumab in Metastatic Urothelial Carcinoma

    • Authors: TURAL, Deniz, et al.
    • Journal: European Urology Focus, 2021, 7.5: 1061-1066

    Pulmonary Sarcomatoid Carcinoma

    • Authors: FERHATOGLU, Ferhat, et al.
    • Journal: Oncology Research and Treatment, 2021, 44.11: 590-601

    Prognostic Factors in Atezolizumab-Treated Urothelial Carcinoma

    • Authors: TURAL, Deniz, et al.
    • Journal: International Journal of Clinical Oncology, 2021, 26.8: 1506-1513

    Atezolizumab with Chemotherapy in Small Cell Lung Cancer

    • Authors: GÜRBÜZ, Mustafa, et al.
    • Journal: Journal of Cancer Research and Clinical Oncology, 2022, 1-9

    FOLFIRINOX vs. Gemcitabine + Nab-Paclitaxel in Pancreatic Cancer

    • Authors: AY, Seval, et al.
    • Journal: Journal of Chemotherapy, 2022, 1-7

    Trastuzumab Emtansine in Older HER2-Positive Breast Cancer Patients

    • Authors: CIL, Ibrahim, et al.
    • Journal: Tumori Journal, 2022, 108.1: 19-25

    Real-Life Efficacy of Osimertinib in Advanced NSCLC

    • Authors: HIZAL, Mutlu, et al.
    • Journal: Journal of Cancer Research and Clinical Oncology, 2022, 148.6: 1501-1508

    ALK-Positive Cells Percentage and Alectinib Efficacy

    • Authors: Hizal, M., Bilgin, B., Paksoy, N., Atcı, M. M., Kahraman, S., Kılıçkap, S., ... & Şendur, M. A. N.
    • Journal: Journal of Cancer Research and Clinical Oncology, 149(8), 4141-4148

    Real-World Data on Alectinib in ALK-Positive NSCLC

    • Authors: Hizal, M., Bilgin, B., Paksoy, N., Kılıçkap, S., Atcı, M. M., Kahraman, S., ... & Şendur, M. A. N.
    • Journal: Future Oncology, 18(23), 2573-2582

    Prognostic Factors in Metastatic RCC with T790M Mutation

    • Authors: Dogan, I., Iribas, A., Paksoy, N., Vatansever, S., & Basaran, M.
    • Journal: Journal of Cancer Research and Therapeutics

    FLOT Regimen in Metastatic Gastric Cancer

    • Authors: Tastekin, D., Paksoy, N., Dogan, I., Ferhatoglu, F., Khanmammadov, N., Bozbey, H. U., & Karabulut, S.
    • Journal: Journal of Cancer Research and Therapeutics

    Desensitization Protocol in Lenalidomide Hypersensitivity Reactions

    • Authors: DEMIR, Semra, et al.
    • Journal: Annals of Allergy, Asthma & Immunology, 2019, 123.4: 394-397

    Factors Associated with Diagnostic Skin Test Positivity in PPI Hypersensitivity

    • Authors: ÖZDEMIR, Seçil Kepil, et al.
    • Journal: Allergy, 2019, 74.6: 1187-1190

    Efficacy of Capecitabine and Temozolomide in Neuroendocrine Tumors

    • Authors: Ünal, Ç., Azizy, A., Karabulut, S., Taştekin, D., Akyıldız, A., Yaşar, S., ... & Sağlam, S.
    • Journal: The Oncologist, oyad257

    Subsequent Treatments in Hormone-Positive Breast Cancer Progression

    • Authors: Karacin, C., Oksuzoglu, B., Demirci, A., Keskinkılıç, M., Baytemür, N. K., Yılmaz, F., ... & Hacıbekiroğlu, İ.
    • Journal: BMC cancer, 23(1), 192

    Termination of Trastuzumab in HER2-Positive Metastatic Breast Cancer

    • Authors: Dogan, I., Aydin, E., Khanmammadov, N., Paksoy, N., Saip, P., & Aydiner, A.
    • Journal: Scientific Reports, 13(1), 8779

    Long-term Outcomes and Predictors of Recurrence in Node-Negative Early Stage Breast Cancer

    • Authors: Dogan, I., Aydin, E., Khanmammadov, N., Paksoy, N., Ferhatoğlu, F., Ak, N., ... & Aydiner, A.
    • Journal: Journal of Cancer Research and Clinical Oncology, 1-9

    Prognostic Factors Influencing PFS in HER2-Positive Metastatic Breast Cancer

    • Authors: Doğan, İ., Paksoy, N., Ak, N., Vatansever, S., Saip, P., & Aydıner, A.
    • Journal: European Journal of Breast Health, 19(2), 128

    Treatment Efficacy of Ribociclib or Palbociclib plus Letrozole in Metastatic Breast Cancer

    • Authors: Kahraman, S., Erul, E., Seyyar, M., Gumusay, O., Bayram, E., Demirel, B. C., ... & Nahit Sendur, M. A.
    • Journal: Future Oncology, 19(10), 727-736

    Efficacy and Safety of Sorafenib in Adult Metastatic Osteosarcoma Patients

    • Authors: Dogan, I., Paksoy, N., & Basaran, M.
    • Journal: Journal of Cancer Research and Therapeutics

    Single-Agent Temozolomide as Salvage Therapy in Heavily Pretreated Metastatic Sarcoma Patients

    • Authors: Dogan, I., Paksoy, N., & Basaran, M.
    • Journal: Journal of Cancer Research and Therapeutics

    Outcomes and Prognostic Factors in Metastatic Renal Cell Carcinoma with Brain Metastases

    • Authors: Dogan, I., Iribas, A., Paksoy, N., Vatansever, S., & Basaran, M.
    • Journal: Journal of Cancer Research and Therapeutics

    FLOT Regimen in First-Line Treatment of Metastatic Gastric Cancer

    • Authors: Tastekin, D., Paksoy, N., Dogan, I., Ferhatoglu, F., Khanmammadov, N., Bozbey, H. U., & Karabulut, S.
    • Journal: Journal of Cancer Research and Therapeutics

    Prognostic Factors of Perioperative FLOT Regimen in Operable Gastric Cancer

    • Authors: Erol, C., Sakin, A., Basoglu, T., Ozden, E., Cabuk, D., Dogan, M., ... & Sendur, M. A. N.
    • Journal: [Not specified]

    Efficacy and Outcomes of Systemic Chemotherapy in Posttransplant Kaposi Sarcoma

    • Authors: Khanmammadov, N., Paksoy, N., Doğan, I., Ferhatoğlu, F., Saip, P., & Aydiner, A.
    • Journal: Medicine, 102(39), e35383

    Comparison of Second-Line Treatments in Metastatic Renal Cell Carcinoma

    • Authors: Pehlivan, M., Paksoy, N., Aydin, E., Basaran, M., & Ekenel, M.
    • Journal: Medicine, 102(41), e35245

    Toxicity Management and Effectiveness of Regorafenib in Advance GIST Patients: A Real-world Study - Authors: Paksoy, N., Ferhatoğlu, F., Doğan, İ., Khanmammadov, N., Bozbey, H. U., Karabulut, S., & Taştekin, D. - Journal: TURKISH JOURNAL OF ONCOLOGY, 1(1)

    Demographic and Clinical Features and Factors Associated with Survival in Patients with Primary Glomerulonephritis: Single Tertiary Center Experience - Authors: Paksoy, N., Trabulus, S., Seyahi, N., & Altiparmak, M. R. - Journal: Namik Kemal Tip Dergisi, 11(1)

    Efficacy of Sorafenib in Symptomatic Patients with Pretreated Progressive Desmoid Tumors - Authors: Paksoy, N., Ferhatoglu, F., Dogan, I., Ak, N., Pehlivan, M., Ekenel, M., & Basaran, M.

    Nodal Response to Neoadjuvant Chemotherapy is a Better Predictive Factor of Survival Than Miller-Payne Scoring in Breast Cancer - Authors: Ak, Naziye, et al. - Journal: Journal of Oncological Sciences, 7.2: 42-49

    Evaluation of Prognostic and Predictive Values of Hemogram Parameters in Patients with Advanced Stage Ovarian Carcinoma - Authors: Ak, Naziye, et al. - Journal: Turkish Journal of Oncology/Türk Onkoloji Dergisi, 2021, 36.4

    Identifying Risk Factors Associated with Survival and Drug-Related Toxicities in Imatinib-Resistant Gastrointestinal Stromal Tumor (GIST) Patients Treated with Sunitinib - Authors: Ferhatoglu, F., Karabulut, S., Paksoy, N., & Tastekin, D.

    Real-life Outcomes of ROS1 Fusion-positive Metastatic Lung Cancer Patients who were Treated with Crizotinib - Authors: Dogan, İ., Khanmammadov, N., Paksoy, N., Ferhatoglu, F., Aydın, E., Vatansever, S., & Aydine, A. - Journal: TURK ONKOLOJI DERGISI-TURKISH JOURNAL OF ONCOLOGY

    Predictors of the acquisition of T790M mutation in EGFR-mutant metastatic lung cancer patients who were treated with EGFR inhibitors - Authors: Dogan, I., Khanmammadov, N., Paksoy, N., Vatansever, S., Saip, P., & Aydıner, A. - Journal: Eurasian Journal of Pulmonology

    Laterality of Adrenal Gland Metastasis in Lung Cancer: Results of a Comparative Study - Authors: Ferhatoglu, F., Gagatay, T., Okumus, G., Aydiner, A., Paksoy, N., Ak, N., ... & Saip, P. - Journal: Eurasian Journal of Medical Investigation, 7(2)

    Poor Risk Factors Affecting Cancer Patients Infected with Covid-19: A Retrospective Comparative Study from a Pandemic Hospital - Authors: Ferhatoglu, F., Kapağan, T., Paksoy, N., Ak, N., Medetalibeyoğlu, A., Şenkal, N., ... & Vatansever, S. - Journal: Turk Onkoloji Dergisi, 38(1)

    Systemic Treatment Outcomes of Progressive Medullary Thyroid Carcinoma from the Registries of a Tertiary Cancer Center - Authors: Ferhatoglu, F., Paksoy, N., & Başaran, M. - Journal: Namik Kemal Tip Dergisi, 10(4)

    Evaluation of clinical features and risk factors related to late recurrence (> 5 years) in patients with breast cancer - Authors: Ferhatoglu, F., Aydiner, A., & Paksoy, N. - Journal: Journal of Surgery & Medicine (JOSAM), 6(12)

    Assessing the Clinical Impact of Lutetium-177 DOTATATE Peptide Receptor Radionuclide Therapy (PRRT) on Metastatic Neuroendocrine Tumors: A Multicenter Real-World Data from Türkiye

     

    Thesis:

    Istanbul University Cerrahpaşa Medical Faculty, Internal Medicine Department PAKSOY, Nail. Demographical, clinical characteristics and survival factors in patients withprimary glomerulonephritis: Cerrahpasa Medical Faculty Experience. (2016)

    International Refereed Congress / Symposium Publications in Proceedings (ASCO/ESMO Abstracts)

    Prognostic factors influencing progression-free survival in HER2 positive metastatic breast cancer patients who treated with lapatinib and capecitabine combination

    • Authors: Dogan, I., Paksoy, N., Ak, N., Vatansever, S., Saip, P., & Aydiner, A. (2022)

    Efficacy of regorafenib and 5-fluorouracil-based rechallenge treatment in the third-line treatment of metastatic colorectal cancer: A Turkish oncology group study

    • Authors: Şenocak Taşçi, E., Oyan, B., Sonmez, O., Mutlu, A. U., Atcı, M. M., Oner, I., ... & Gulmez, A. (2022)

    Long-term outcomes and predictors of recurrence in patients with early-stage node-negative breast cancer

    • Authors: Dogan, I., Aydin, E., Paksoy, N., Ferhatoglu, F., Ak, N., Ibis, K., ... & Aydiner, A. (2021)

    Efficacy of temozolomide in pretreated patients with metastatic sarcoma

    • Authors: Paksoy, N., Dogan, I., Ekenel, M., & Basaran, M. (2021)

    Efficacy of sorafenib in symptomatic patients with pretreated progressive desmoid tumors

    • Authors: Ferhatoglu, F., Paksoy, N., Dogan, I., Ak, N., Pehlivan, M., Ekenel, M., & Basaran, M. (2021)

    Efficacy of sorafenib in heavily pretreated adult patients with metastatic osteosarcoma

    • Authors: Paksoy, N., Dogan, I., Ekenel, M., & Basaran, M. (2021)

    Outcomes and prognostic factors in metastatic renal cell carcinoma patients with brain metastases

    • Authors: Dogan, İ., Iribas, A., Paksoy, N., Ekenel, M., Vatansever, S., & Basaran, M. (2021)

    Association of response to first-line chemotherapy with the efficacy of atezolizumab in patients with metastatic urothelial carcinoma

    • Authors: Tural, D., Olmez, O. F., Sümbül, A. T., Artac, M., Ozhan, N., Akar, E., ... & Erman, M. (2021)

    Safety and survival in adult women with platinum-sensitive relapsed BRCA mutant ovarian cancer: A study of patients in Olaparib Turkey Early Access Program—LynTurk study

    • Authors: Esin, E., Ahmed, M. A., Yıldırım, H. Ç., Mandel, N. M., Erdemoglu, E., Sari, M., ... & Paydas, S. (2023)

    Atezolizumab in patients with metastatic urothelial carcinoma who have progressed after first-line chemotherapy: Results of real-life experiences

    • Authors: Tural, D., Ölmez, Ö. F., Sümbül, A. T., Artaç, M., Özhan, N., Akar, E., ... & Kılıçkap, S. (2021)

     

     

  • Read more
Doctor's visit
Price on request
Info

Osman Kostek

  • 5 Excellent 3 reviews
  • 21 years of experience
  • Turkey, Istanbul, Medipol Acibadem District Hospital
  • Education

    • (2004 – 2011), Faculty of Medicine/ Inonu University/ Malatya, Turkiye
    • (2011 – 2015), Department of Radiology/ Bagcilar Training and Research Hospital/ Istanbul, Turkiye

    Career

    • (2016 – 2020), Diagnostic and Interventional Radiologist/ Mus State Hospital/ Mus,Turkiye
    • (2020 – 2022), Assistant Professor of Diagnostic and Interventional Radiology/ Sakarya University Training and Research Hospital/ Sakarya, Turkiye
    • (2023 – 2024), Associate Professor of Diagnostic and Interventional Radiology /Sakarya University Training and Research Hospital/ Sakarya, Turkiye
    • (2024 - Present), Associate Professor of Diagnostic and Interventional Radiology /Medipol University Hospital/ Istanbul, Turkiye
  • Read more
Doctor's visit
Price on request
Info

Mustafa Serkan Alemdar

  • 3 Good 1 review
  • 19 years of experience
  • Turkey, Antalya , Medical Park Antalya Hospital Complex
  • Education and Specialization

    • 2006: Kocaeli University Faculty of Medicine
    • 2014: Akdeniz University Faculty of Medicine, Internal Medicine
    • 2018: Akdeniz University Faculty of Medicine, Medical Oncology

    Experience

    • 2006 - 2008: Konya Derebucak District Hospital
    • 2009 - 2015: Akdeniz University Hospital
    • 2015: Antalya Kaş State Hospital
    • 2015 - 2016: İnönü University Faculty of Medicine
    • 2016 - 2021: Akdeniz University Hospital
    • 2021 - 2023: Antalya Training and Research Hospital
  • Read more
Hormone therapy
$1,100 - $1,100
Info

Sherko Kuemmel

  • New
  • 28 years of experience
  • Cyprus, Republic of Cyprus, German Medical Institute (GMI)
  •  Posts and Affiliations

    Clinical Director – Multidisciplinary Breast Unit Kliniken Essen-Mitte, Germany

    Lead Breast Cancer Research Program, Kliniken Essen-Mitte

    Executive Board Member of the AGO (Arbeitsgemeinschaft Gynäkologische Onkologie)

     Additional Roles

    ESMO Faculty – Breast Cancer

    Member of AWO Gyn – Commission for plastic and reconstructive surgery

    Speaker of the AGIMed – Commission for Integrative Medicine of the AGO

    Member of the Organ Commission Mamma of the AGO

    Scientific Director of the WSG study group

    Global PI, Head of clinical investigations and trials 27

    IDMC´s, Steering Boards national and international

    Scientific committee of international and national symposia in breast cancer and surgical oncology

     Organization Memberships

    Memberships: European Society of Medical Oncology, American Society of Clinical Oncology,

    European Academy of Senology, German Cancer Society, German Society of Gynecology and

    Obstetrics, Working Group for Gynecological Oncology, German Society of Senology,

     Publications

    Peer reviewed Publications: 322

    First/Senior Author: 38

    h-Index/i10-Index 66/232

    Congress Abstracts/Proceedings: 443

    Books/Book Chapter: 59

    Invited oral Presentations/Lectures: 1032

  • Read more
Doctor's visit
Price on request
Info

Jacob Schechter

  • 5 Excellent 2 reviews
  • Israel, Ramat Gan, Sheba Medical Center
  • Specialist in Oncodermatology

Doctor's visit
Price on request
Info

Cho Jae-Yong

  • 4.5 Good 42 reviews
  • Republic of Korea, Seoul, Severance Hospital
  • Oncologist

Doctor's visit
Price on request
Info

Ilker Kahramanoglu

  • New
  • 16 years of experience
  • Turkey, Istanbul, Prof. Dr. Ilker Kahramanoglu Clinic
  • He was born in 1985 in Antalya. He completed his primary and secondary education in Antalya. Between 2003 and 2009, he studied at the Cerrahpaşa Medical Faculty of Istanbul University. In 2009, he started his residency in Obstetrics and Gynecology at the Istanbul Suleymaniye Obstetrics and Pediatrics Education and Research Hospital. During his residency, he worked in obstetrics, Gynecology, Oncology, Endoscopic Surgery, Perinatology (high-risk pregnancy), Infertility and Menopause units.

    In 2011, he spent two months in India studying actively on laparoscopy at World Laparoscopy Hospital. In 2014, he received the title of Obstetrician and Gynecologist. In the same year, he came 2nd in Turkey in the examination for Minor Specialty in Medicine and started his minor residency in Gynecological Oncology Surgery at Istanbul University Cerrahpasa Faculty of Medicine, Department of Obstetrics and Gynecology.

    In 2017, he worked for three months at Memorial Sloan Kettering Cancer Center in New York, United States. In 2018, he became a minor specialist in Gynecological Oncology Surgery. In the same year, the European Society of Gynecological Oncology awarded him the personally accredited European Gynecologist Oncologist certificate (3rd person in Turkey). For about 1.5 years, he served at Gazi Yaşargil Training and Research Hospital under the Obligation of Civil Service. In 2019, he participated in active surgery and cadaver work together with Michael Höckel, one of the pioneers of Gynecological Oncology at the University of Leipzig, Leipzig, Germany. That same year, he was a “visiting fellow” at the Catholic University of the Sacred Heart in Rome, Italy.

    He was awarded the title of Associate Professor in August 2019. He participated in numerous national and international congresses, symposiums and workshops and served as guest speaker. His surgery videos have been selected as training videos by the European Society of Gynecological Oncology and are published on their site for doctors.

    He has 56 international and 10 national publications. He was the editor of the Turkish translation of the book, which is considered the main international source in Gynecological Oncology. He is the author of 7 chapters of international and national books. He has over 100 works in Turkey and abroad as oral presentations, poster presentations and panel presentations. He is refereeing for internationally respected journals. He has a good command of English. He follows up and implements all developments in his field.

  • Read more
Doctor's visit
Price on request
Info

Professor Volker Budach

  • New
  • 45 years of experience
  • Germany, Berlin, Privatpraxis Vosspalais
  • Prof. Dr. med. Volker Budach *Prof. Dr.med. Volker Budach

    He completed his medical studies at the University of Essen and was appointed to the Department of Radiotherapy at the Charité Hospital in Berlin in 1993. He successfully headed this department until 2022, with almost 40 years of professional and 30 years of managerial experience. Under the direction of Prof. Dr. Budach, numerous clinical studies were conducted, especially in the therapy of head and neck tumors. Along with other tumors such as sarcomas, bronchial carcinomas and breast carcinomas, which are his clinical and scientific focus. Prof. Dr. Budach founded and for many years jointly directed the comprehensive cancer center at the Charité. In addition to his function as director of the clinic, he also headed the Charité Center 14, which combined the topics of imaging and oncology. Prof. Budach was President of the German Society for Radiation Oncology (DEGRO) and President of its congress. At the EORTC, he headed the head and neck tumour group for many years. He is the author of numerous important papers on the optimisation of radiotherapy and chemotherapy in the treatment of head and neck tumours. After 30 years of leading the clinic, Prof. Dr. Budach decided to transfer his experience in radiation oncology to the RadioOnkologie Vosspalais clinic. Prof. Dr. Budach is a member of the professional associations DEGRO, ESTRO, ASTRO.

  • Read more
Doctor's visit
Price on request
Info

Choosing Right Doctor and Clinic: Insider Tips

When selecting a doctor or clinic, keep these key points in mind:
Check credentials
Verify certifications from bodies like ISAPS, JCI, etc.
Review success rates
Choose doctors with solid experience in your specific treatment.
Read patient reviews
Browse Bookimed reviews from real patients to learn about their experiences.
Ensure effective communication
Pick clinics that offer language support for a smooth treatment process.
Ask about services
Confirm if they provide accommodation and transfers, and check the costs.
Choosing a clinic abroad can be stressful. At Bookimed, with over 800K patients helped, we understand your concerns. We know how to find trusted doctors, the best price-quality options, and solutions for even complex cases. We’re here to guide you every step of the way.
Yan Matsiivskiy
Head of Medical Coordinator Team